XstalBio Limited is an advanced drug delivery company.
Its core competence lies in the formulation and stabilisation of biomolecules using its proprietary Protein-coated microcrystal technology (“PCMC”).
XstalBio’s aim is to be a leading drug delivery company on the strength of it’s innovation, diversification and range of licensing opportunities.
XstalBio’s strategy is to develop the PCMC technology in collaboration with the biopharmaceutical industry.
The technology has the potential to improve the therapeutic value and extend the applications of protein-based drugs, to accelerate their development and to extend product life-cycles.